Exact Sciences Highlights the Impact of Precision Oncology P

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...

Related Keywords

Canada , San Antonio , Texas , United States , Quebec , United Kingdom , Josepha Sparano , Gisela Pedroza , Rick Baehner , Federico Maiardi , Megan Jones , Sciences Corp , Sciences On Facebook , National Cancer Institute , Sciences On Twitter Exactsciences , Cancer Research Group , Nasdaq , Exchange Commission , Genomic Health Inc , Sciences Precision Oncology Portfolio , Cancer Research Network , Sciences Corporation , Exact Science , Exact Sciences , Precision Oncology , Antonio Breast Cancer , Recurrence Score , Research Group , Trial Assigning Individualized Options , Tisch Cancer Center , Mount Sinai Health , Positive Node , Endocrine Responsive Breast Cancer , Research Network , New England Journal , Exact Sciences Precision Oncology Portfolio , Scottish Conservation , Breast Recurrence , Oncomap Extra , Exact Science Precision Oncology , Science Precision Oncology , Genomic Health , Risk Factors , Annual Report , Quarterly Reports , Exact Sciences Corp , Health Care Amp Hospitals , Medical Pharmaceuticals , Computer Amp Electronics , Medical Equipment , Otc , Mallcap , Clinical Trials Amp Medical Discoveries ,